Centro de Salud Francia
- Address
- Calle de Francia, 38, 28943 Fuenlabrada, Spain
Centro de Salud Francia - Respiratory Disease Research
Centro de Salud Francia is a specialized medical research facility dedicated to advancing the understanding and treatment of chronic respiratory conditions. The center demonstrates particular expertise in conducting pragmatic clinical trials that evaluate real-world treatment strategies for patients with Chronic Obstructive Pulmonary Disease (COPD), focusing on optimizing therapeutic outcomes for high-risk patient populations.
- Comparative effectiveness studies of triple therapy versus dual bronchodilator combinations in COPD management
- Clinical control assessment methodologies incorporating stability and impact domains
- Targeted treatment strategies for high-risk GOLD B COPD patients
The center specializes in open-label, randomized controlled trials designed to improve clinical control in patients with complex respiratory disease profiles. Their research emphasizes practical, patient-centered approaches to COPD management, particularly for individuals classified as GOLD B+ who may benefit from intensified therapeutic interventions beyond standard dual bronchodilator therapy.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centro de Salud Francia
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized Controlled Trial Comparing the Efficacy of Umeclidinium Bromide, Fluticasone Furoate, and Vilanterol Versus LABA-LAMA Combination in High-Risk COPD Patients | Fundacio Privada Mon Clinic Barcelona | Phase III | Not Recruiting | Feb 2024 | Jan 2025 |
IMP list
lock Showing 1 of 15 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aclidinium Bromide | 1 | Unknown | 2024-02-09 | 2024-02-09 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.